Schroder Investment Management Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.41M | Sell |
266,927
-2,553
| -0.9% | -$80.5K | 0.01% | 666 |
|
|
2025
Q1 | $8.7M | Sell |
269,480
-29,177
| -10% | -$942K | 0.01% | 663 |
|
|
2024
Q4 | $11M | Sell |
298,657
-216,640
| -42% | -$8M | 0.01% | 642 |
|
|
2024
Q3 | $15.8M | Buy |
515,297
+7,200
| +1% | +$221K | 0.02% | 578 |
|
|
2024
Q2 | $13.6M | Buy |
508,097
+150,416
| +42% | +$4.02M | 0.02% | 572 |
|
|
2024
Q1 | $12.2M | Sell |
357,681
-184,292
| -34% | -$6.29M | 0.01% | 609 |
|
|
2023
Q4 | $15.7M | Buy |
+541,973
| New | +$15.7M | 0.02% | 538 |
|
|
2020
Q3 | – | Sell |
-1,360
| Closed | -$32K | – | 1388 |
|
|
2020
Q2 | $32K | Sell |
1,360
-10,900
| -89% | -$256K | ﹤0.01% | 1200 |
|
|
2020
Q1 | $224K | Sell |
12,260
-881
| -7% | -$16.1K | ﹤0.01% | 1088 |
|
|
2019
Q4 | $312K | Buy |
+13,141
| New | +$312K | ﹤0.01% | 1112 |
|
|
2018
Q3 | – | Sell |
-15,343
| Closed | -$895K | – | 1335 |
|
|
2018
Q2 | $895K | Buy |
15,343
+76
| +0.5% | +$4.43K | ﹤0.01% | 950 |
|
|
2018
Q1 | $699K | Buy |
15,267
+1,643
| +12% | +$75.2K | ﹤0.01% | 1011 |
|
|
2017
Q4 | $543K | Buy |
13,624
+5,160
| +61% | +$206K | ﹤0.01% | 1086 |
|
|
2017
Q3 | $333K | Buy |
+8,464
| New | +$333K | ﹤0.01% | 1135 |
|